论文信息 - Phase I Dose-Escalation Study of Anti–CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers - 字舞流文

Phase I Dose-Escalation Study of Anti–CTLA-4 Antibody Ipilimumab and Lenalidomide in Patients with Advanced Cancers

F. Janku | A. Naing | D. Hong | J. Wheler | A. Tsimberidou | G. Falchook | V. Subbiah | S. Fu | I. Glitza | M. Cabanillas | M. Fanale | Sonia L. Betancourt Cuellar | D. Sakamuri